(Q34182194)

31 July 2017

1 reference

title

Azithromycin: indications for the future? (English)

1 reference

31 July 2017

0 references

Duran JM

1

1 reference

PubMed ID

11249533

31 July 2017

Amsden GW

series ordinal

2

1 reference

PubMed ID

11249533

31 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

1 reference

31 July 2017

1

1 reference

31 July 2017

3

1 reference

31 July 2017

489-505

1 reference

The role of advanced generation macrolides in the prophylaxis and treatment of Mycobacterium avium complex (MAC) infections

31 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Intravenous azithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Azithromycin prophylaxis against a chloroquine-resistant strain of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Pharmacokinetics of azithromycin in trachoma patients: serum and tear levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Randomised controlled trial of single-dose azithromycin in treatment of trachoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Chlamydia pneumoniae and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Short-term treatment of pertussis with azithromycin in infants and young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Treatment failure in erythema migrans--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Update on the management of intestinal cryptosporidiosis in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Combination drug therapy for cryptosporidiosis in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Azithromycin vs. doxycycline for Mediterranean spotted fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

Inhibition of motility ofPseudomonas aeruginosa andProteus mirabilis by subinhibitory concentrations of azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.3.489

21 January 2018

Identifiers

DOI

10.1517/14656566.1.3.489

1 reference

31 July 2017

1 reference

PubMed ID

11249533